Edition:
United Kingdom

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

0.75USD
8:43pm GMT
Change (% chg)

$0.04 (+5.06%)
Prev Close
$0.71
Open
$0.76
Day's High
$0.79
Day's Low
$0.74
Volume
181,313
Avg. Vol
85,566
52-wk High
$3.38
52-wk Low
$0.60

Latest Key Developments (Source: Significant Developments)

Biocept Inc Says Signed An In-Network Provider Agreement With Wellmark Inc
1:05pm GMT 

Dec 18 (Reuters) - Biocept Inc ::BIOCEPT INC - HAS SIGNED AN IN-NETWORK PROVIDER AGREEMENT WITH WELLMARK INC.  Full Article

Sabby Management LLC Reports A 9.20 Pct Passive Stake In Biocept
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Biocept Inc ::SABBY MANAGEMENT LLC REPORTS A 9.20 PCT PASSIVE STAKE IN BIOCEPT INC <<>> AS OF DEC 5 - SEC FILING.  Full Article

Biocept announces pricing of public offering of up to 4,925,936 shares of common stock
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Biocept Inc ::BIOCEPT ANNOUNCES PRICING OF PUBLIC OFFERING OF UP TO 4,925,936 SHARES OF COMMON STOCK.BIOCEPT - ‍PRICED BEST EFFORTS REGISTERED PUBLIC OFFERING OF UP TO 4.9 MILLION SHARES OF CO'S COMMON STOCK AT PRICE TO PUBLIC OF $0.68/SHARE​.  Full Article

Biocept files for offering $10 mln of shares of co's common stock and warrants
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Biocept Inc :Biocept Inc files for offering $10 million of shares of co's common stock and warrants - SEC Filing.Biocept - shares of co's common stock and warrants are immediately separable and will be issued separately, but will be purchased together in the offering.  Full Article

Biocept reports Q3 loss per share $0.20
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Biocept Inc :Biocept reports third quarter 2017 financial results.Q3 loss per share $0.20.Q3 revenue rose 6 percent to $1.1 million.Biocept Inc - ‍cash and cash equivalents were $5.9 million as of September 30, 2017​.  Full Article

Biocept reports pricing of $10 million public offering of common stock and warrants
Friday, 14 Oct 2016 

Biocept Inc :Biocept Inc - pricing of an underwritten public offering of 9.1 million shares of its common stock and warrants at a combined offering price of $1.10.  Full Article

Biocept says board approved reverse stock split at ratio of 1:3
Thursday, 29 Sep 2016 

Biocept Inc : Proposal to amend co's certificate of amendment of certificate of incorporation approved by stockholders at special meeting - SEC filing . Amendment to increase authorized number of shares of company's common stock from 40 million to 150 million shares .Board approved a reverse stock split of company's common stock at a ratio of 1:3.  Full Article

Biocept reports agreement with Teneovita Medical
Tuesday, 30 Aug 2016 

Biocept Inc: Biocept announces agreement with Teneovita Medical to market and distribute its Liquid Biopsy testing platform in Canada .Preferred provider agreement with Teneovita Medical, a division of Teneovita Medical Innovations Inc..  Full Article

Biocept files for common stock offering of up to $10 mln
Friday, 12 Aug 2016 

Biocept Inc :Files for common stock offering of up to $10 million - SEC Filing.  Full Article

Biocept expands distribution of liquid biopsy tests to Philippines
Thursday, 11 Aug 2016 

Biocept Inc : Biocept expands distribution of liquid biopsy tests to the Philippines . Additional terms of transaction were not disclosed . All diagnostic testing services under agreement will be performed in Biocept's San Diego-based CLIA-certified laboratory . Enters into agreement with Harlephil Ventures .Harlephil Ventures, Inc to have responsibility for sales, marketing, distribution, and reimbursement of company's liquid biopsy platform.  Full Article

BRIEF-Biocept Inc Says Signed An In-Network Provider Agreement With Wellmark Inc

* BIOCEPT INC - HAS SIGNED AN IN-NETWORK PROVIDER AGREEMENT WITH WELLMARK INC Source text for Eikon: Further company coverage: